Curio
Curio Digital Therapeutics is a company focused on women's mental health, leveraging AI and digital-first solutions. They offer evidence-based behavioral health interventions supported by health coaches and therapists, accessible anytime and anywhere. Curio has developed proprietary technology, including Curio-i, an AI-driven predictive algorithm that identifies women at risk for postpartum depression with high accuracy. Their product MamaLift & MamaLift Plus provides on-demand therapy lessons, health trackers, and live health coaches. Curio emphasizes scientific rigor, with multiple clinical studies and a unique position as the only company with an FDA-authorized Prescription Digital Therapeutic (PDT) for postpartum depression symptoms. They aim to shift the paradigm of women's healthcare by providing contextualized care across life stages like fertility, childbirth, and menopause.
Curio
Curio Digital Therapeutics is a company focused on women's mental health, leveraging AI and digital-first solutions. They offer evidence-based behavioral health interventions supported by health coaches and therapists, accessible anytime and anywhere. Curio has developed proprietary technology, including Curio-i, an AI-driven predictive algorithm that identifies women at risk for postpartum depression with high accuracy. Their product MamaLift & MamaLift Plus provides on-demand therapy lessons, health trackers, and live health coaches. Curio emphasizes scientific rigor, with multiple clinical studies and a unique position as the only company with an FDA-authorized Prescription Digital Therapeutic (PDT) for postpartum depression symptoms. They aim to shift the paradigm of women's healthcare by providing contextualized care across life stages like fertility, childbirth, and menopause.